Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rothschild & Co Asset Management is the dedicated investment management division of the Rothschild & Co group, providing a broad range of active management solutions to institutional and private clients. Although the firm does not develop therapeutic products, it is a key player in the life sciences sector through its specialized thematic investment strategies, such as those focused on the 'Silver Economy' and healthcare innovation. The firm's portfolios frequently include significant holdings in global pharmaceutical, biotechnology, and medical technology companies. Additionally, the broader Rothschild & Co group is a leading advisor in healthcare mergers and acquisitions, making the firm a central figure in the financial landscape of the biotech industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rothschild Asset Management.